Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen

Emilia Sánchez Ruiz, Rebeca Lahoz, Antoni Noguera, Núria Rovira, Albert Català-Temprano, Rafael Jiménez, Clàudia Fortuny

Research output: Indexed journal article Article

23 Citations (Scopus)

Abstract

Recent updates of the guidelines on the prevention of human immunodeficiency virus mother-to-child transmission have shortened the neonatal zidovudine prophylactic regimens from 6 to 4 weeks. We present a prospective observational study in a large cohort of mother-infant pairs and report that the 4-week regimen allows an earlier recovery of the anemia in these otherwise healthy infants.
Original languageEnglish
Pages (from-to)376-379
Number of pages4
JournalPediatric Infectious Disease Journal
Volume29
Issue number4
DOIs
Publication statusPublished - 1 Apr 2010

Keywords

  • Hematologic toxicity
  • Human Immunodeficiency virus
  • Pediatrics
  • Neonatal prophylaxis
  • Zidovudine

Fingerprint

Dive into the research topics of 'Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen'. Together they form a unique fingerprint.

Cite this